OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical Use of Pharmacotherapy for Obesity
Leon I. Igel, Rekha B. Kumar, Katherine H. Saunders, et al.
Gastroenterology (2017) Vol. 152, Iss. 7, pp. 1765-1779
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
Andrés Acosta, Michael Camilleri, Barham Abu Dayyeh, et al.
Obesity (2021) Vol. 29, Iss. 4, pp. 662-671
Open Access | Times Cited: 124

Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants
Ziyi Zhou, J Macpherson, Stuart R. Gray, et al.
Diabetologia (2021) Vol. 64, Iss. 9, pp. 1963-1972
Open Access | Times Cited: 104

Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice
Bo Xia, Xiaochen Shi, Baocai Xie, et al.
PLoS Biology (2020) Vol. 18, Iss. 3, pp. e3000688-e3000688
Open Access | Times Cited: 113

Best Practices in the Management of Overweight and Obesity
Beverly G. Tchang, Katherine H. Saunders, Leon I. Igel
Medical Clinics of North America (2020) Vol. 105, Iss. 1, pp. 149-174
Closed Access | Times Cited: 80

Characterization of on-target adverse events caused by TRK inhibitor therapy
D. Liu, James Flory, Andrew Lin, et al.
Annals of Oncology (2020) Vol. 31, Iss. 9, pp. 1207-1215
Open Access | Times Cited: 64

Introduction
Robert F. Kushner, Scott Kahan
Medical Clinics of North America (2018) Vol. 102, Iss. 1, pp. 1-11
Closed Access | Times Cited: 62

Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
João Victor da Silva Guerra, Marieli M. G. Dias, Anna Julyana Viana Chianca Brilhante, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2830-2830
Open Access | Times Cited: 48

Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial
Christopher C. Thompson, Barham K. Abu Dayyeh, Vladimir Kushnir, et al.
Surgery for Obesity and Related Diseases (2019) Vol. 15, Iss. 8, pp. 1348-1354
Open Access | Times Cited: 49

The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
Minyi Lee, Brianna N. Lauren, Tiannan Zhan, et al.
Obesity Science & Practice (2019) Vol. 6, Iss. 2, pp. 162-170
Open Access | Times Cited: 48

FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway
Feiyu Lu, Mujie Ye, Chunhua Hu, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3553-3567
Open Access | Times Cited: 14

Fighting obesity: Non-pharmacological interventions
María Fernanda Higuera-Hernández, Elena Reyes-Cuapio, Marissa Gutiérrez-Mendoza, et al.
Clinical Nutrition ESPEN (2018) Vol. 25, pp. 50-55
Open Access | Times Cited: 37

Advances in Obesity: Causes, Consequences, and Therapy
Hans‐Rudolf Berthoud, Samuel Klein
Gastroenterology (2017) Vol. 152, Iss. 7, pp. 1635-1637
Closed Access | Times Cited: 31

Ginkgetin, a biflavone from Ginkgo biloba leaves, prevents adipogenesis through STAT5-mediated PPARγ and C/EBPα regulation
Young‐Lai Cho, Jong‐Gil Park, Hyo Jin Kang, et al.
Pharmacological Research (2018) Vol. 139, pp. 325-336
Closed Access | Times Cited: 31

Pharmacologic Treatment of Overweight and Obesity in Adults
Beverly G. Tchang, Rekha B. Kumar, Louis J. Aronne
(2021)
Closed Access | Times Cited: 23

Devices and Endoscopic Bariatric Therapies for Obesity
Katherine H. Saunders, Leon I. Igel, Monica Saumoy, et al.
Current Obesity Reports (2018) Vol. 7, Iss. 2, pp. 162-171
Closed Access | Times Cited: 25

Effect of liraglutide 3.0mg treatment on weight reduction in obese antipsychotic-treated patients
Seung Eun Lee, Nam Young Lee, Se Hyun Kim, et al.
Psychiatry Research (2021) Vol. 299, pp. 113830-113830
Closed Access | Times Cited: 20

Training in Bariatric and Metabolic Endoscopic Therapies
Pichamol Jirapinyo, Christopher C. Thompson
Clinical Endoscopy (2018) Vol. 51, Iss. 5, pp. 430-438
Open Access | Times Cited: 23

Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction
Leon I. Igel, Katherine H. Saunders, Joseph J. Fins
Current Atherosclerosis Reports (2018) Vol. 20, Iss. 8
Closed Access | Times Cited: 22

Pharmacotherapy of Obesity: Limits and Perspectives
Pamela Rosa-Gonçalves, David Majerowicz
American Journal of Cardiovascular Drugs (2019) Vol. 19, Iss. 4, pp. 349-364
Closed Access | Times Cited: 22

Jatrorrhizine from Rhizoma Coptidis exerts an anti-obesity effect in db/db mice
Huan He, Jianling Deng, Maochun Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 298, pp. 115529-115529
Closed Access | Times Cited: 11

SICOB-endorsed national Delphi consensus on obesity treatment optimization: focus on diagnosis, pre-operative management, and weight regain/insufficient weight loss approach
Marco Antonio Zappa, Angelo Iossa, Luca Busetto, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top